Search results

It has been reported that the RECOVER initiative has secured an additional $200M in funding for clinical trials.

To discuss this, go to this thread: USA: The RECOVER Initiative - Long Covid research

Hmmm. Works for me. What do you get instead? Oh I see that it's paywalled. I took the quotes from someone on twitter with access to it. Thread with many more quotes: https://nitter.net/ZurNull/status/1735158834795012445.

62% follow-up data. No controls or randomization, in fact there is a selection process. Retrospective evaluation. They're basically working around the most basic requirements of EBM by simply framing this as routine service evaluation from an existing clinic that assumes the treatments are...

Business press continues to do a far better job covering the impacts of COVID. It affects the bottom line and productivity of companies everywhere. What companies can do against Long Covid Harvard Business Manager...

Unfortunately, this is where the difference between book smart and smart lies. General intelligence is very hard to assess, and the entire schooling system pretty much ignores it, it's too diffuse, too hard to develop. It rewards people who are able to quickly answer questions, whether or not...

‘It’s all gone’: CAR-T therapy forces autoimmune diseases into remission https://www.nature.com/articles/d41586-023-03968-6 Engineered immune cells have given 15 people with once-debilitating autoimmune disorders a new lease on life, free from fresh symptoms or treatments. The results raise...

Generic fluff. People don't like bad things happening to them. People like good things happening to them. Groundbreaking stuff.

ChatGPT outperforming human doctors in behavioral, cognitive, and psychological–related questions is both hilarious and not the least bit surprising. This is by far the weakest area in all medicine, and the gap will only grow wider. AIs don't read between the lines or see thinly veiled language...

Performance of Large Language Models on a Neurology Board–Style Examination JAMA Neurology: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2812620 Key Points Question What is the performance of large language models on neurology board–style examinations? Findings In this...

Posting this because it seems to continue the usual problem in evidence-based medicine where conclusions are simply not supported by their own data. This is a systematic review of systematic reviews, making a positive recommendation for SSRIs, despite acknowledging that there is no good...

Efficacy and Safety of Antidepressants in Patients With Comorbid Depression and Medical Diseases An Umbrella Systematic Review and Meta-Analysis JAMA Psychiatry: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2809163 Key Points Question What is the evidence for use of...

Poorly-run trial of two identical biased open label interventions finds no difference in outcomes: "yeah this is good I guess they're both great!". The entire methodology is built around comparing outcomes, itself fraught with issues, and they don't even bother with that. And all such "tailored"...

The excessive focus on psychosocial does not inspire confidence. It's not what patients need. And it's not what patients want, because it's not what they need. Until there are disease-modifying treatments, this is always a waste of effort and resources. If anything, it's doctors who need...

Moved post Tweet has a link to this week's StatCan report and shows this image:

Several people noticed that last year's StatCan data reported 1.4M people with suspected Long Covid. This year's report is 3.5M, with 58% of those reporting to have ever had symptoms still have them. This image made the rounds and was roundly ridiculed by MDs, but it's tracking rather well...

Probably a bit of that, but also mostly having to do with the "not otherwise explained by a known diagnosis" qualifier. Reaching their 70's, people usually have multiple diagnoses, and general fatigue can and will always be put down to ageing, regardless of the age of the patient.